Hinge Health (HNGE) - EV/EBITDA Multiple

HNGE (Hinge Health Corp) - company brandmark

Hinge Health Inc (HNGE) does not pay dividends, as its success depends on the adoption of telemedicine by insurers and the effectiveness of remote therapy. The company's EV/EBITDA ratio, accounting for debt load, serves as a confidence indicator, and the current value of this metric is 57.95. Growth is driven by AI sensors that replace clinics, while business resilience is based on the deep integration of software into the employee benefit packages of major US corporate behemoths.

HNGE Hinge Health, Inc.: Enterprise Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/12/2026

HNGE (hingehealth.com): analytical breakdowns and indicator data

- current price and projected stock value:
Stock Price Hinge Health Corp|HNGE - Fair Value Consensus
- market capitalization indicators:
Market Capitalization Hinge Health Platform|HNGE - Company Buyout Price
- issuer book value statistics:
Net Assets per Single Share Hinge Health|HNGE - Accounting Capitalization|Market Capitalization to Book Value Ratio hingehealth.com|HNGE - Company Balance Sheet Assets
- company liabilities and liquidity data:
Total Debt to Capital Hinge Health Inc|HNGE - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Hinge Health|HNGE - Aggregate Debt Obligations|Debts to Book Capitalization Hinge Health Platform|HNGE - Company Long-Term Loans and Borrowings|Company Short-Term Debts Hinge Health|Quick Ratio hingehealth.com
- business earnings and investment ratios data:
HNGE - Net Profit|Expected Profit Hinge Health Inc|HNGE - Price to Earnings Ratio|Projected Price to Earnings Hinge Health Inc|HNGE - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Hinge Health Platform|HNGE - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months Hinge Health|HNGE - Earnings per share for the trailing year|Quarterly EPS earnings growth hingehealth.com|HNGE - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Hinge Health Inc
Summary company analysis:Hinge Health Corp HNGE
Product sample of Hinge Health, Inc.

This indicator determines the total business value relative to its operating profit before depreciation, taxes, and interest, allowing for an assessment of the company's ability to service its debt. By analyzing the EV/EBITDA multiple trend, an investor can see the efficiency of Hinge Health (HNGE) B2B contract monetization, where growth in margins and ROI for employers directly reduces the debt burden on capital.

Key competitors

EV/EBITDA Multiple HIMS (Hims)|Business Value to Operating Income Before Depreciation TDOC|Talkspace, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio LifeMD, Inc. LFMD|Amwell (AMWL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation MGRX|DRIO (DarioHealth Corporation) - EV/EBITDA Multiple|VSEE - Enterprise Value to EBITDA Multiple|EV/EBITDA Multiple MNDR|ACCD - Company Value to EBITDA|Biotricity - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation LYT|Catasys - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation SHLT (SHL Telemedicine Ltd.)|THRN: EV/EBITDA Multiple